Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma.
Faye MD, Easaw J, De Robles P, Agnihotram R, Torres-Vasquez A, Lamonde F, Petrecca K, Owen S, Panet-Raymond V, Shenouda G, Souhami L, Azam M, Hossain B, Alkass J, Sabri S, Abdulkarim B. Faye MD, et al. Among authors: owen s. Neurooncol Adv. 2023 Sep 12;5(1):vdad106. doi: 10.1093/noajnl/vdad106. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37771465 Free PMC article.
Progression pattern and adverse events with bevacizumab in glioblastoma.
Mamo A, Baig A, Azam M, Rho YS, Sahebjam S, Muanza T, Owen S, Petrecca K, Guiot MC, Al-Shami J, Sharma R, Kavan P. Mamo A, et al. Among authors: owen s. Curr Oncol. 2016 Oct;23(5):e468-e471. doi: 10.3747/co.23.3108. Epub 2016 Oct 25. Curr Oncol. 2016. PMID: 27803607 Free PMC article.
A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma.
Shenouda G, Souhami L, Petrecca K, Owen S, Panet-Raymond V, Guiot MC, Corredor AG, Abdulkarim B. Shenouda G, et al. Among authors: owen s. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):487-494. doi: 10.1016/j.ijrobp.2016.11.006. Epub 2016 Nov 15. Int J Radiat Oncol Biol Phys. 2017. PMID: 28011051 Clinical Trial.
Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases.
Wong P, Masucci L, Florescu M, Plourde ME, Panet-Raymond V, Pavic M, Owen S, Masson-Coté L, Ménard C, Routy B, Tehfe M, Nelson K, Guilbert F, Boucher O, Keshavarzi S, Blais N, Roberge D. Wong P, et al. Among authors: owen s. Neurooncol Adv. 2023 Mar 1;5(1):vdad018. doi: 10.1093/noajnl/vdad018. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37025758 Free PMC article.
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
Pilon Y, Rokah M, Seitlinger J, Sepesi B, Rayes RF, Cools-Lartigue J, Najmeh S, Sirois C, Mulder D, Ferri L, Abdulkarim B, Ezer N, Fraser R, Camilleri-Broët S, Fiset PO, Wong A, Sud S, Langleben A, Agulnik J, Pepe C, Shieh B, Hirsh V, Ofiara L, Owen S, Spicer JD. Pilon Y, et al. Among authors: owen s. Clin Lung Cancer. 2024 May;25(3):e133-e144.e4. doi: 10.1016/j.cllc.2023.12.005. Epub 2023 Dec 19. Clin Lung Cancer. 2024. PMID: 38378398
927 results